Skip Nav Destination
Close Modal
Update search
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-4 of 4
Keywords: Abiraterone
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Journal:
Urologia Internationalis
Urol Int (2026) 110 (2): 198–201.
Published Online: 12 July 2025
...Moustafa Elleisy; Irene Resch; Ozan Yurdakul; Nicolai A. Hübner; Shahrokh Shariat Introduction: Abiraterone acetate is an inhibitor of androgen biosynthesis and is approved as a treatment for metastatic castration-resistant and metastatic castration-sensitive prostate cancer. Neither relugolix nor...
Journal Articles
Clinical Experience of Steroid Switch from Prednisone to Dexamethasone in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2021) 105 (5-6): 380–385.
Published Online: 13 August 2020
... included postdocetaxel patients with mCRPC treated with abiraterone acetate combined with prednisone (AA + P) who had experienced prostate-specific antigen (PSA) progression. All patients underwent a steroid switch from prednisone (10 mg/day) to dexamethasone (1 mg/day). The PSA level and clinical symptoms...
Journal Articles
AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC
Available to PurchaseSubject Area:
Further Areas
Holger Hans Herman Erb, Peter Sparwasser, Tamara Diehl, Manuela Hemmerlein-Thomas, Igor Tsaur, Eva Jüngel, Ulrich Sommer, Gustavo B. Baretton, Axel Haferkamp, Andreas Neisius, Christian Thomas
Journal:
Urologia Internationalis
Urol Int (2020) 104 (3-4): 253–262.
Published Online: 17 January 2020
... = 26) before, while, and after undergoing a new therapy with chemotherapy (cabazitaxel or docetaxel) or antiandrogen (enzalutamide or abiraterone). CTCs were sequentially cytospun on object slides, and AR-V7 status was then detected by IHC based on a staining regime established on a 22Rv1 cell line...
Journal Articles
Cytochrome P450 17A1 Inhibitor Abiraterone Acetate Counteracts the Heat Shock Protein 27's Cell Survival Properties in Prostate Cancer Cells
Available to PurchaseSubject Area:
Further Areas
Martin Weiss, Hannes Ahrend, Hannah Grossebrummel, Patrick Ziegler, Lars-Ove Brandenburg, Reinhard Walther, Uwe Zimmermann, Martin Burchardt, Matthias B. Stope
Journal:
Urologia Internationalis
Urol Int (2016) 97 (1): 112–117.
Published Online: 24 March 2016
...Martin Weiss; Hannes Ahrend; Hannah Grossebrummel; Patrick Ziegler; Lars-Ove Brandenburg; Reinhard Walther; Uwe Zimmermann; Martin Burchardt; Matthias B. Stope Introduction: Inhibition of androgen synthesis by abiraterone acetate (AA) entails enhanced overall survival rates and clinical benefit...
